Specific hypoxia regulated genes such as HIF (hypoxia inducible factor), VEGFA (vascular endothelial growth factor A) and CA9 (carbonic anhydrase 9) have been identified as promising targets for cancer therapy or as diagnostic/prognostic markers in clinical research5, 6, 7. Here, CA9 is linked to cancer.